Back

Trends and outcomes of intravascular imaging in patients undergoing percutaneous coronary intervention for coronary chronic total occlusion: a 5-year retrospective analysis

25 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: The utility of IVUS in various clinical presentations Intracoronary Ultrasound ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Errol Moras

Mount Sinai Health System, New York (United States of America)

6 More presentations in this session

Presentation thumbnail
Evaluation of the residual myocardial ischemia after PCI to long diffuse left anterior descending artery lesions: comparison of IVUS vs FFR
Doctor P. Budrys (Klaipeda, LT)
Abstract Slides Video
Presentation thumbnail
Impact of intravascular ultrasound parameters on revascularization decision in grey zone fractional flow reserve: data from IRIS FFR registry
Doctor D. Kang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Intracoronary imaging of complex coronary artery lesions: A lesion-level analysis from SCAAR simulating the IMPROVE trial
Mr S. Von Koch (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Discordance between quantitative coronary angiography and fractional flow reserve or intravascular ultrasound: a substudy of the FLAVOUR trial
Professor S. Ahn (Wonju, KR)
Abstract Slides Video
Presentation thumbnail
Impact of intracoronary imaging-guided percutaneous coronary intervention on procedural outcomes among patients with cardiogenic shock
Doctor M. Mohamed (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
The utility of IVUS in various clinical presentations

The Event

Event poster

ESC Congress 2023

25 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Have a look inside: intracoronary imaging
thumbnail
Congress Presentation
Intravascular imaging: can we still ignore the evidence?
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources